REAL

Items where Author is "Szarvas, Tibor"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 44.

Article

Fazekas, Tamás and Dér, Bálint and Csizmarik, Anita and Soós, Áron and Fekete, Bálint and Nyirády, Péter and Szarvas, Tibor (2023) Új utak a prosztatarák terápiájában: a genetikai mintázat szerepe a célzott kezelések kiválasztásában = New approaches in the therapy of prostate cancer: The role of genetic patterns in selecting targeted treatments. Magyar Urológia, 35 (2). pp. 75-78. ISSN 0864-8921

Módos, Orsolya and Váradi, Melinda and Dér, Bálint and Keszthelyi, Attila and Szűcs, Miklós and Reis, Henning and Nyirády, Péter and Szarvas, Tibor (2023) Az urachuscarcinoma aktuális diagnosztikai és kezelési lehetőségei = Current diagnostic and treatment strategies for urachal cancer. ORVOSI HETILAP, 164 (16). pp. 602-609. ISSN 0030-6002

Tóth, Gábor and Sugár, Simon and Pál, Domonkos and Fügedi, Kata Dorina and Drahos, László and Schlosser, Gitta and Oláh, Csilla and Reis, Henning and Kovalszky, Ilona and Szarvas, Tibor and Turiák, Lilla (2022) Glycosaminoglycan Analysis of FFPE Tissues from Prostate Cancer and Benign Prostate Hyperplasia Patients Reveals Altered Regulatory Functions and Independent Markers for Survival. CANCERS, 14 (19). No-4867. ISSN 2072-6694

Szarvas, Tibor and Reis, Henning (2022) Commentary: Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal Tumor. FRONTIERS IN ONCOLOGY. ISSN 2234-943X

Keresztes, Dávid and Csizmarik, Anita and Nagy, Nikolett and Módos, Orsolya and Fazekas, Tamás and Bracht, Thilo and Sitek, Barbara and Witzke, Kathrin and Puhr, Martin and Sevcenco, Sabina and Kramer, Gero and Shariat, Shahrokh F and Küronya, Zsófia and Takács, László and Tornyi, Ilona and Lázár, József and Hadaschik, Boris and Lászik, András and Szűcs, Miklós and Nyirády, Péter and Szarvas, Tibor (2022) Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration-resistant prostate cancer. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 26. pp. 1332-1337. ISSN 1582-1838

Kovács, Petra and Mayer, Tamás and Csizmarik, Anita and Váradi, Melinda and Oláh, Csilla and Széles, Ádám and Tschirdewahn, Stephan and Krafft, Ulrich and Hadaschik, Boris and Nyirády, Péter and Riesz, Péter and Szarvas, Tibor (2022) Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma. BIOMEDICINES, 10. No. 698. ISSN 2227-9059

Ingenwerth, Marc and Nyirády, Péter and Hadaschik, Boris and Szarvas, Tibor and Reis, Henning (2022) The Prognostic Value of Cytokeratin and Extracellular Collagen Expression in Urinary Bladder Cancer. Current molecular medicine, 222. pp. 941-949.

Csizmarik, Anita and Keresztes, Dávid and Nagy, Nikolett and Bracht, Thilo and Sitek, Barbara and Witzke, Kathrin and Puhr, Martin and Tornyi, Ilona and Tímár, József and Takács, László and Kramer, Gero and Sevcenco, Sabina and Maj-Hes, Agnieszka and Jurányi, Zsolt and Hadaschik, Boris and Nyirády, Péter and Szarvas, Tibor (2022) Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer. INTERNATIONAL JOURNAL OF CANCER. ISSN 0020-7136

Reider, Balazs and Gacsi, Eszter and Jankovics, Hajnalka and Vonderviszt, Ferenc and Szarvas, Tibor and Guttman, Andras and Jarvas, Gabor (2021) Integrated workflow for urinary prostate specific antigen N-glycosylation analysis using sdAb partitioning and downstream capillary electrophoresis separation. ANALYTICA CHIMICA ACTA. p. 338892. ISSN 0003-2670

Krafft, Ulrich and Oláh, Csilla and Reis, Henning and Kesch, Claudia and Darr, Christopher and Grünwald, Viktor and Tschirdewahn, Stephan and Hadaschik, Boris and Horváth, Orsolya and Kenessey, István and Nyirády, Péter and Váradi, Melinda and Módos, Orsolya and Csizmarik, Anita and Szarvas, Tibor (2021) High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy. CANCERS, 13. No. 2548. ISSN 2072-6694

Csizmarik, Anita and Hadaschik, Boris and Kramer, Gero and Nyirády, Péter and Szarvas, Tibor (2021) Mechanisms and markers of resistance to androgen signaling inhibitors in patients with metastatic castration-resistant prostate cancer. Urologic Oncology, 39 (10). 728.e13-728.e24. ISSN 1078-1439

Maj-Hes, Agnieszka and Szarvas, Tibor and Sevcenco, Sabina and Kramer, Gero (2021) Multiple Docetaxel Retreatments Without Prednisone for Metastatic Castration-Resistant Prostate Cancer in the Docetaxel-Only Era: Effects on PSA Kinetics and Survival. Advances in Therapy, 38. pp. 3831-3841. ISSN 1865-8652

Oláh, Csilla and Tschirdewahn, Stephan and Hoffmann, Michele and Krafft, Ulrich and Hadaschik, Boris and Nyirády, Péter and Szendrői, Attila and Módos, Orsolya and Csizmarik, Anita and Kovalszky, Ilona and Reis, Henning and Szarvas, Tibor (2021) Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients. Diagnostics. No. 864. ISSN 2075-4418

Oláh, Csilla and Váradi, Melinda and Horváth, Orsolya and Nyirády, Péter and Szarvas, Tibor (2021) A béltartalom és a vizelet mikrobiom-összetételének onkológiai vonatkozásai. Orvosi Hetilap, 162 (15). pp. 579-586. ISSN 0030-6002

Nagy, Noémi Dalma and Fazekas, Tamás and Baghy, Kornélia and Papp, Gergely and Csizmarik, Anita and Szűcs, Miklós and Nyirády, Péter and Szarvas, Tibor (2021) A karboplatin-kemoterápia hatékonysága egy áttétes, kasztrációrezisztens, BRCA2-mutáció-pozitív prosztatarákos betegben = Efficacy of carboplatin chemotherapy in a metastatic, castration-resistant BRCA2 mutation positive prostate cancer patient. Orvosi Hetilap, 162 (25). pp. 1004-1008. ISSN 0030-6002

Neumann, Judith and Niehaus, Kerstin and Neumann, Nils and Knobloch, Hans and Bremmer, Felix and Krafft, Ulrich and Kellner, Udo and Nyirády, Péter and Szarvas, Tibor and Bednarz, Hanna and Reis, Henning (2021) A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer. Laboratory investigation; a journal of technical methods and pathology, 101. pp. 1281-1288. ISSN 1530-0307

Szarvas, Tibor and Csizmarik, Anita and Váradi, Melinda and Fazekas, Tamás and Hüttl, András and Nyirády, Péter and Hadaschik, Boris and Grünwald, Viktor and Tschirdewahn, Stephan and Shariat, Shahrokh F and Sevcenco, Sabina and Maj-Hes, Agnieszka and Kramer, Gero (2021) The prognostic value of serum MMP-7 levels in prostate cancer patients who received docetaxel, abiraterone, or enzalutamide therapy. Urologic Oncology, 39 (5). 296.e11-296.e19. ISSN 1078-1439

Oláh, Csilla and Hahnen, Christina and Nagy, Nikolett and Musial, Johanna and Váradi, Melinda and Nyírő, Gábor and Győrffy, Balázs and Hadaschik, Boris and Rawitzer, Josefine and Ting, Saskia and Sjödahl, Gottfrid and Hoffmann, Michele and Reis, Henning and Szarvas, Tibor (2021) A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer-Stromal gene expressions show higher prognostic values than intrinsic tumor genes. INTERNATIONAL JOURNAL OF CANCER, 150 (5). pp. 856-867. ISSN 0020-7136

Fazekas, Tamás and Csizmarik, Anita and Szarvas, Tibor and Szűcs, Miklós and Nyirády, Péter (2020) A COVID-19-kutatás uroonkológiai vonatkozásai = Uro-Oncologic Aspects of COVID-19 Research. Magyar Urológia, 32 (2). pp. 61-63. ISSN 0864-8921

Szarvas, Tibor and Csizmarik, Anita and Habina-Nagy, Nikolett and Keresztes, Dávid and Váradi, Melinda and Küronya, Zsófia and Riesz, Péter and Nyirády, Péter (2020) Az áttétes kasztrációrezisztens prosztatarák gyógyszer-rezisztenciájának molekuláris vonatkozásai. ORVOSI HETILAP, 161 (20). pp. 813-820. ISSN 0030-6002

Szarvas, Tibor and Hoffmann, Michele and Oláh, Csilla and Székely, Eszter and Kiss, András and Hess, Jochen and Tschirdewahn, Stephan and Hadaschik, Boris and Grotheer, Vera and Nyirády, Péter and Csizmarik, Anita and Váradi, Melinda and Reis, Henning (2020) MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients. Diagnostics. ISSN 2075-4418

Nagy, Nikolett and Reis, Henning and Hadaschik, Boris and Niedworok, Christian and Módos, Orsolya and Szendrői, Attila and Bíró, Krisztina and Hager, Thomas and Herold, Thomas and Ablat, Jason and Black, Peter and Okon, Krzysztof and Tolkach, Yuri and Csizmarik, Anita and Oláh, Csilla and Keresztes, Dávid and Bremmer, Felix and Gaisa, Nadine T and Kriegsmann, Joerg and Kovalszky, Ilona and Kiss, András and Tímár, József and Szász, Attila Marcell and Rink, Michael and Fisch, Margit and Nyirády, Péter and Szarvas, Tibor (2020) Prevalence of APC and PTEN Alterations in Urachal Cancer. Pathology oncology research : POR, 26. pp. 2773-2781. ISSN 1532-2807

Kovács, Petra Terézia and Juhász, Dániel and Módos, Orsolya and Kocsmár, Ildikó and Terebessy, András and Lotz, Gábor and Szarvas, Tibor and Nyirády, Péter and Riesz, Péter (2020) A húgyhólyag-recidíva jellemzői felső üregrendszeri daganatos betegekben radikális ureteronephrectomia után. ORVOSI HETILAP, 161 (21). pp. 881-888. ISSN 0030-6002

Módos, Orsolya and Bozsaki, Ákos and Nagy, Cintia and Nagy, Nikolett and Csizmarik, Anita and Keresztes, Dávid and Oláh, Csilla and Váradi, Melinda and Horváth, András and Szendrői, Attila and Szűcs, Miklós and Keszthelyi, Attila and Nyirády, Péter and Szarvas, Tibor (2019) A platinaalapú kemoterápia szerepe a húgyhólyagrák kezelésében - az elmúlt 10 év klinikai tapasztalatainak feldolgozása = Platinum-based chemotherapy in urinary bladder cancer - 10 years clinical experiences. Magyar Urológia, 31 (2). pp. 58-65. ISSN 0864-8921

Reis, Henning and Szarvas, Tibor and Grünwald, Viktor (2019) Prädiktive Biomarker in der onkologischen Uropathologie. Der Pathologe, 40 (3). pp. 264-275. ISSN 0172-8113

Maj-Hes, Agnieszka and Sevcenco, Sabina and Szarvas, Tibor and Kramer, Gero (2019) Claros System: A Rapid Microfluidics-Based Point-of-Care System for Quantitative Prostate Specific Antigen Analysis from Finger-Stick Blood. Advances in Therapy, 36 (4). pp. 916-922. ISSN 1865-8652

Küronya, Zsófia and Sükösd, Farkas and Varga, Linda and Bíró, Krisztina and Gyergyay, Fruzsina and Géczi, Lajos and Nagyiványi, Krisztián and Jorgo, Kliton and Szarvas, Tibor and Kovács, Ágnes and Laczó, Ibolya and Varga, Zoltán and Pósfai, Boglárka and Pepó, Judit and Maráz, Anikó (2019) ERG expression can predict the outcome of docetaxel combinedwith androgen deprivation therapy in metastatic hormone-sensitiveprostate cancer. Urologic Oncology, 37 (4). 289.e1-289.e9. ISSN 1078-1439

Szarvas, Tibor and Oláh, Csilla and Reis, Henning (2019) Neoadjuvant cisplatin-based chemotherapy in “primary” and “secondary” muscle-invasive bladder cancer—is it a surrogate for molecular subtypes? Translational Cancer Research, 8. pp. 176-179. ISSN 2219-6803

Szarvas, Tibor and Oláh, Csilla and Riesz, Péter and Géczi, Lajos and Nyirády, Péter (2019) A húgyhólyag urothelialis daganatainak molekuláris alcsoportbeosztása és annak klinikai vonatkozásai = Molecular subtype classification of urothelial bladder cancer and its clinical relevance. Orvosi Hetilap, 160 (42). pp. 1647-1654. ISSN 0030-6002

Szarvas, Tibor and Csizmarik, Anita and Szűcs, Miklós and Nyirády, Péter (2019) A prosztatarák molekuláris altípusai és célzott terápiás kilátásai. Orvosi Hetilap, 160 (7). pp. 252-263. ISSN 0030-6002

Szarvas, Tibor and Csizmarik, Anita and Szűcs, Miklós and Nyirády, Péter (2019) A prosztatarák molekuláris altípusai és célzott terápiás kilátásai = Molecular subtypes and perspectives of targeted therapies in prostate cancer. Orvosi Hetilap, 160 (7). pp. 252-263. ISSN 0030-6002

Darr, Christopher and Krafft, Ulrich and Hadaschik, Boris and Tschirdewahn, Stephan and Sevcenco, Sabina and Csizmarik, Anita and Nyirády, Péter and Küronya, Zsófia and Reis, Henning and Maj-Hes, Agnieszka and Shariat, Shahrokh F and Kramer, Gero and Szarvas, Tibor (2018) The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate Cancer. UROLOGIA INTERNATIONALIS, 101 (1). ISSN 0042-1138

Reis, H. and Krafft, U. and Niedworok, C. and Módos, Orsolya and Herold, T. and Nyirády, Péter and Szarvas, Tibor (2018) Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data. DISEASE MARKERS. No.-7308168. ISSN 0278-0240

Szarvas, Tibor and Sevcenco, Sabina and Módos, Orsolya and Keresztes, Dávid and Nyirády, Péter and Csizmarik, Anita (2018) Matrix metalloproteinase 7, soluble Fas and Fas ligand serum levels for predicting docetaxel resistance and survival in castration-resistant prostate cancer. BJU INTERNATIONAL, 122 (4). pp. 695-704. ISSN 1464-4096 (print); 1464-410X (online)

Reis, Henning and van der Vos, Kristan E. and Niedworok, Christian and Herold, Thomas and Módos, Orsolya and Szendrői, Attila and Keresztes, Dávid and Nagy, Nikolett and Kovalszky, Ilona and Tímár, József and Nyirády, Péter and Szarvas, Tibor (2018) Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas. INTERNATIONAL JOURNAL OF CANCER (4). pp. 1-22. ISSN 0020-7136

Szarvas, Tibor and Sevcenco, Sabina and Módos, Orsolya and Keresztes, Dávid and Nyirády, Péter and Kubik, András and Romics, Miklós and Kovalszky, Ilona (2018) Syndecan-1 shedding circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancer. UROLOGIC ONCOLOGY: SEMINARS AND ORIGINAL INVESTIGATIONS, 36 (6). pp. 1-7. ISSN 1078-1439

Kubik, András and Szarvas, Tibor and Módos, Orsolya and Keresztes, Dávid and Horváth, András and Nyirády, Péter (2017) A felső húgyúti urothel sejtes tumorok kezelése-hasonlóságok és különbségek a húgyhólyag urothelialis tumoraival = Management of urothelial carcinoma of the upper urinary tract -similarities and differences with urothelial bladder cancer. Magyar Urológia, 29 (2). pp. 52-56. ISSN 0864-8921

Reis, Henning and Niedworok, Christian and Szarvas, Tibor (2017) Response to: Absence of GNAS and BRAF mutations but presence of KRAS mutation in urachal adenocarcinoma. PATHOLOGY, 49 (5). pp. 561-562. ISSN 0031-3025 (print); 1465-3931 (online)

Niedworok, C. and Tschirdewahn, S. and Reis, H. and Lehmann, N. and Szűcs, Miklós and Nyirády, Péter and Romics, Imre and Szarvas, Tibor (2017) Serum Chromogranin A as a Complementary Marker for the Prediction of Prostate Cancer-Specific Survival. PATHOLOGY AND ONCOLOGY RESEARCH, 23 (3). pp. 643-650. ISSN 1219-4956

Thiem, Sebastian and Herold, Thomas and Krafft, Ulrich and Bremmer, Felix and Tolkach, Yuri and Szász, Attila Marcell and Kriegsmann, Joerg and Gaisa, Nadine T and Niedworok, Christian and Szarvas, Tibor and Reis, Henning (2017) Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer. Pathology International, 67. pp. 597-601. ISSN 1320-5463, ESSN: 1440-1827

Módos, Orsolya and Reis, Henning and Niedworok, Christian and Rübben, Herbert and Szendröi, Attila and Szász, Marcell A and Tímár, József and Baghy, Kornélia and Kovalszky, Ilona and Golabek, Tomasz and Chlosta, Piotr and Okon, Krzysztof and Peyronnet, Benoit and Mathieu, Romain and Shariat, Shahrokh F and Hollósi, Péter and Nyirády, Péter and Szarvas, Tibor (2016) Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma - occurence and prognostic significance. Oncotarget. pp. 39293-39301. ISSN 1949-2553

Nyirády, Péter and Niedworok, Christian and Reis, Henning and Szarvas, Tibor (2016) Clinical Sequencing-guided Therapy of Urachal Carcinoma: New Perspective for a Rare Cancer. EUROPEAN UROLOGY, 70 (5). pp. 776-777. ISSN 0302-2838

Jász, Krisztián and Szarvas, Tibor (2005) Az esélyegyenlõségi politika Janus-arca : kistelepülések, társadalmak, konfliktusok. Politikatudományi Szemle, 14 (2). pp. 135-155. ISSN 1216-1438

Suba, János and Légrády, György and Pozsár, Béla and Szarvas, Tibor (1980) A Fotoszintetikus 14CO2 Fixálás és А С: N viszony évszakos változásai A "Síkfőkút Project" Cseres-tölgyes fajainál. Folia historico-naturalia Musei Matraensis, 6. pp. 83-98. ISSN 0134-1243

This list was generated on Fri Mar 29 16:23:55 2024 CET.